BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 20818067)

  • 1. Effect of docetaxel on expression of eIF3a in human lung cancer A549 cell line.
    Gong Z; Xu X; Hou R; Guo Y; Sheng F; Ouyang D; Zhou H; Liu Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 35(8):771-6. PubMed ID: 20818067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors.
    Fulzele SV; Chatterjee A; Shaik MS; Jackson T; Ichite N; Singh M
    Anticancer Drugs; 2007 Jan; 18(1):65-78. PubMed ID: 17159504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enhancement effect of nucleotide excision repair gene xeroderma pigmentosun group a antisense RNA on sensitivity of human lung adenocarcinoma cell line A549 to cisplatin].
    Fan W; Zhang HL; Wu XM
    Ai Zheng; 2005 Apr; 24(4):403-7. PubMed ID: 15820060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutation in beta-tubulin and a sustained dependence on androgen receptor signalling in a newly established docetaxel-resistant prostate cancer cell line.
    Hara T; Ushio K; Nishiwaki M; Kouno J; Araki H; Hikichi Y; Hattori M; Imai Y; Yamaoka M
    Cell Biol Int; 2010 Jan; 34(2):177-84. PubMed ID: 19947927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of eIF3a on response of lung cancer patients to platinum-based chemotherapy by regulating DNA repair.
    Yin JY; Shen J; Dong ZZ; Huang Q; Zhong MZ; Feng DY; Zhou HH; Zhang JT; Liu ZQ
    Clin Cancer Res; 2011 Jul; 17(13):4600-9. PubMed ID: 21610145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. eIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27Kip1 translation.
    Zhang Y; Yu JJ; Tian Y; Li ZZ; Zhang CY; Zhang SF; Cao LQ; Zhang Y; Qian CY; Zhang W; Zhou HH; Yin JY; Liu ZQ
    Oncotarget; 2015 Sep; 6(28):25441-51. PubMed ID: 26213845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2 downregulation sensitizes nonsmall cell lung cancer cells to cisplatin, but not to docetaxel.
    Losert D; Pratscher B; Soutschek J; Geick A; Vornlocher HP; Müller M; Wacheck V
    Anticancer Drugs; 2007 Aug; 18(7):755-61. PubMed ID: 17581297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, pharmacophores, and mechanism study of pyridin-2(1H)-one derivatives as regulators of translation initiation factor 3A.
    Zhu W; Shen J; Li Q; Pei Q; Chen J; Chen Z; Liu Z; Hu G
    Arch Pharm (Weinheim); 2013 Sep; 346(9):654-66. PubMed ID: 23959654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle effects of fatty acid derivatives of cytarabine, CP-4055, and of gemcitabine, CP-4126, as basis for the interaction with oxaliplatin and docetaxel.
    Adema AD; Laan AC; Myhren F; Fichtner I; Verheul HM; Sandvold ML; Peters GJ
    Int J Oncol; 2010 Jan; 36(1):285-94. PubMed ID: 19956857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma cell sensitivity to Docetaxel-induced apoptosis is determined by class III beta-tubulin levels.
    Mhaidat NM; Thorne RF; de Bock CE; Zhang XD; Hersey P
    FEBS Lett; 2008 Jan; 582(2):267-72. PubMed ID: 18086570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of eIF3a in regulating cell cycle progression.
    Dong Z; Liu Z; Cui P; Pincheira R; Yang Y; Liu J; Zhang JT
    Exp Cell Res; 2009 Jul; 315(11):1889-94. PubMed ID: 19327350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of tubulin by docetaxel is associated with p53 status in human non small cell lung cancer cell lines.
    Chang JT; Chang GC; Ko JL; Liao HY; Liu HJ; Chen CC; Su JM; Lee H; Sheu GT
    Int J Cancer; 2006 Jan; 118(2):317-25. PubMed ID: 16080190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance-associated protein 7 expression is involved in cross-resistance to docetaxel in salivary gland adenocarcinoma cell lines.
    Naramoto H; Uematsu T; Uchihashi T; Doto R; Matsuura T; Usui Y; Uematsu S; Li X; Takahashi M; Yamaoka M; Furusawa K
    Int J Oncol; 2007 Feb; 30(2):393-401. PubMed ID: 17203221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of antisense RNA targeting Polo-like kinase 1 on cell cycle of lung cancer cell line A549].
    Zhou Q; Bai M; Su Y
    Ai Zheng; 2005 Feb; 24(2):149-54. PubMed ID: 15694023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
    Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
    Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of hepatitis C virus translation initiation by iron: role of eIF3 and La protein.
    Wang Q; Liu Y; An D; Diao H; Xu W; He X; Sun R; Wei L; Li L
    Virus Res; 2012 Aug; 167(2):302-9. PubMed ID: 22634302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.
    Feng B; Wang R; Chen LB
    Cancer Lett; 2012 Apr; 317(2):184-91. PubMed ID: 22120675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
    Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of docetaxel-induced apoptosis of human melanoma cells by different isoforms of protein kinase C.
    Mhaidat NM; Thorne RF; Zhang XD; Hersey P
    Mol Cancer Res; 2007 Oct; 5(10):1073-81. PubMed ID: 17951407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.